Segall Bryant & Hamill LLC lessened its stake in shares of HealthSouth Corp (NYSE:HLS) by 1.6% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 184,510 shares of the company’s stock after selling 3,008 shares during the period. Segall Bryant & Hamill LLC owned approximately 0.19% of HealthSouth worth $8,552,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. First Mercantile Trust Co. increased its position in HealthSouth by 18.8% during the 2nd quarter. First Mercantile Trust Co. now owns 2,720 shares of the company’s stock valued at $132,000 after buying an additional 430 shares in the last quarter. Acrospire Investment Management LLC increased its position in HealthSouth by 64.7% during the 2nd quarter. Acrospire Investment Management LLC now owns 2,800 shares of the company’s stock valued at $136,000 after buying an additional 1,100 shares in the last quarter. Advisor Group Inc. increased its position in HealthSouth by 33.8% during the 2nd quarter. Advisor Group Inc. now owns 3,092 shares of the company’s stock valued at $149,000 after buying an additional 781 shares in the last quarter. Petrus Trust Company LTA bought a new position in HealthSouth during the 2nd quarter valued at approximately $210,000. Finally, HL Financial Services LLC bought a new position in HealthSouth during the 2nd quarter valued at approximately $213,000. 93.37% of the stock is owned by institutional investors.

HealthSouth Corp (NYSE HLS) opened at $49.21 on Friday. The firm has a market capitalization of $4,852.62, a price-to-earnings ratio of 17.69, a P/E/G ratio of 1.81 and a beta of 0.54. The company has a current ratio of 1.34, a quick ratio of 1.34 and a debt-to-equity ratio of 1.89. HealthSouth Corp has a 52-week low of $38.24 and a 52-week high of $50.41.

HealthSouth (NYSE:HLS) last released its earnings results on Thursday, October 26th. The company reported $0.66 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.65 by $0.01. The company had revenue of $995.60 million for the quarter, compared to the consensus estimate of $985.75 million. HealthSouth had a return on equity of 22.81% and a net margin of 6.69%. HealthSouth’s quarterly revenue was up 7.4% compared to the same quarter last year. During the same period in the previous year, the business earned $0.65 earnings per share. equities analysts anticipate that HealthSouth Corp will post 2.72 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, January 16th. Stockholders of record on Tuesday, January 2nd will be issued a $0.25 dividend. The ex-dividend date is Friday, December 29th. This represents a $1.00 annualized dividend and a dividend yield of 2.03%. HealthSouth’s dividend payout ratio (DPR) is 36.36%.

In other news, Director Yvonne M. Curl bought 1,000 shares of HealthSouth stock in a transaction dated Wednesday, November 1st. The shares were purchased at an average cost of $45.95 per share, with a total value of $45,950.00. Following the completion of the acquisition, the director now owns 64,144 shares of the company’s stock, valued at approximately $2,947,416.80. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Insiders own 1.60% of the company’s stock.

HLS has been the subject of a number of research analyst reports. Stephens initiated coverage on HealthSouth in a report on Thursday, August 31st. They issued an “overweight” rating and a $53.00 target price for the company. William Blair reissued an “outperform” rating on shares of HealthSouth in a report on Tuesday, November 21st. Robert W. Baird reissued a “buy” rating and issued a $55.00 target price on shares of HealthSouth in a report on Monday, October 9th. Piper Jaffray Companies reissued a “hold” rating and issued a $50.00 target price on shares of HealthSouth in a report on Sunday, September 17th. Finally, KeyCorp restated a “hold” rating on shares of HealthSouth in a research note on Thursday, September 7th. Two investment analysts have rated the stock with a sell rating, four have issued a hold rating and six have issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus target price of $51.75.

WARNING: “Segall Bryant & Hamill LLC Has $8.55 Million Position in HealthSouth Corp (HLS)” was published by Watch List News and is the sole property of of Watch List News. If you are reading this article on another publication, it was stolen and reposted in violation of United States & international copyright laws. The correct version of this article can be viewed at https://www.watchlistnews.com/segall-bryant-hamill-llc-has-8-55-million-position-in-healthsouth-corp-hls/1753910.html.

About HealthSouth

HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.

Want to see what other hedge funds are holding HLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthSouth Corp (NYSE:HLS).

Institutional Ownership by Quarter for HealthSouth (NYSE:HLS)

Receive News & Ratings for HealthSouth Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corp and related companies with Analyst Ratings Network's FREE daily email newsletter.